BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 07/11/2017

FDA Announces Guidance for Industry on Developing Direct-Acting Antiviral Drugs for Chronic Hepatitis C Treatment

The US Food and Drug Administration (FDA) has released a guidance document to help pharmaceutical companies develop direct-acting antiviral (DAA) drugs for treating chronic hepatitis C virus infection, finalizing a draft issued in 2016.

Source: Federal Register — Food and Drug AdministrationOpen original release →